Dear Renana, You don't say if your samples can be inactivated in any way that would kill the viruses without affecting your cytokine measurement. You will need to talk to your Biological Safety Advisor or your local equivalent to get clear guidelines. In UK, samples where the presence of a Hazard group 3 pathogen such as HBV and HCV is confirmed would require to be handled in a containment level 3 laboratory. You will need to perform a Risk Assessment to identify the hazards that your procedure involves and then put in places appropriate measures to avoid, or if not possible, minimize operator exposure. I assume most of the people that will be in contact with the samples will be already HepB vaccinated, otherwise you might want to consider adding this to the list of precautions. Hope this help Mara Mara Rocchi BVM&S, PhD Flow Cytometry Manager Moredun Research Institute Pentlands Science Park Bush Loan, Penicuik EH260PZ Scotland, UK Think before you print. Save paper and help the environment ________________________________ From: Renana Patoka [mailto:Renana@canfite.co.il] Sent: 25 June 2008 07:32 To: cyto-inbox Subject: Safety of serum samples on Flow Cytometry Dear fellows, We are looking at HCV and HBV patients and would like to look at the cytokines in the patients serum by Flow Cytometry. What special precautions should we use? A general guideline on how serum samples should be used on FACS will be appreciated also. Thanks, Renana Patoka -------------------------------------------------------------------------- Moredun Research Institute is a company registered in Scotland, No: SC149440 Moredun Research Institute is a charity registered in Scotland, No: SC022353 Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, EH26 0PZ Disclaimv101Received on Thu Jun 26 21:38:00 2008
This archive was generated by hypermail 2.1.8 : Wed Jan 31 2007 - 03:12:00 EST